MedPath

To evaluate the effectiveness and acceptability of the fluoridated toothpaste to prevent plaque and gum diseases in children in the age group of 6 to 12 years

Phase 3
Registration Number
CTRI/2024/02/062692
Lead Sponsor
Avoden pvt ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects with plaque score 1

Subjects with gingival scores 1 and 2

Subjects showing signs of mild marginal gingival inflammation

Subjects parent or guardian who agree to comply with all study requirements and are able to follow the study directions.

Exclusion Criteria

gingival scores more than 2

orthodontic bands and five or more carious lesions

History of allergies

Subject on antibiotics

Subject with five or more carious lesions requiring immediate restorative treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the plaque and gingival scores <br/ ><br> <br/ ><br>Changes in the clinical signs of gingival inflammation <br/ ><br> <br/ ><br> <br/ ><br>Changes in the clinical signs of gingival inflammation <br/ ><br> <br/ ><br>Timepoint: Plaque and gingival score to be assessed at 1 monthi.e at 1st followup 2 months i.e at2nd followup and 3 months i.e at 3rd followup
Secondary Outcome Measures
NameTimeMethod
nderstanding products acceptability through survey data pointsTimepoint: acceptability and tolerability to be assessed after 1 month
© Copyright 2025. All Rights Reserved by MedPath